Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLC is a research paper published in Bioorganic & Medicinal Chemistry Letters (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P30 GM124165
NIH
Grant: P41 GM103403
Argonne National Laboratory
Grant: DE-AC02-06CH11357
Israel National Road Safety Authority
Grant: 1F32CA247198-01
Studies of mutant-selective allosteric inhibitors of EGFR for non-small cell lung cancer
NCI NIH HHS
Grant: F32 CA247198
NCI NIH HHS
Grant: R01 CA201049
NCI NIH HHS
Grant: P01 CA154303
National Institutes of Health
Grant: 3P30GM124165-03S1
NE-CAT: A Resource for Advanced Macromolecular Crystallography
National Institutes of Health
Grant: 5P41GM103403-15
NE-CAT Center for Advanced Macromolecular Crystallography
Takeda Pharmaceuticals U.S.A.
Novartis Institutes for BioMedical Research
FWCI
1.99
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals